CN114350595A - Lentiviral titer detection method for HEK293TS suspension cells - Google Patents

Lentiviral titer detection method for HEK293TS suspension cells Download PDF

Info

Publication number
CN114350595A
CN114350595A CN202210047969.9A CN202210047969A CN114350595A CN 114350595 A CN114350595 A CN 114350595A CN 202210047969 A CN202210047969 A CN 202210047969A CN 114350595 A CN114350595 A CN 114350595A
Authority
CN
China
Prior art keywords
hek293ts
virus
cells
suspension cells
titer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210047969.9A
Other languages
Chinese (zh)
Inventor
代真真
刘启慧
胡迪超
隋礼丽
钱浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Boteng Biopharmaceutical Co ltd
Original Assignee
Suzhou Boteng Biopharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Boteng Biopharmaceutical Co ltd filed Critical Suzhou Boteng Biopharmaceutical Co ltd
Priority to CN202210047969.9A priority Critical patent/CN114350595A/en
Publication of CN114350595A publication Critical patent/CN114350595A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051Methods of production or purification of viral material
    • C12N2740/15052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Abstract

The invention discloses a method for detecting lentivirus titer of HEK293TS suspension cells, which comprises the following steps: adjusting the density of HEK293TS suspension cells and mixing; spreading a proper amount of HEK293TS suspension cells in a 24-well plate; pre-diluting the lentivirus solution by multiple times, adding a proper amount of pre-diluted virus solution into each hole of a 24-hole plate, and supplementing a proper amount of virus diluent to ensure that the volumes of the virus solutions in the holes are the same; using CO2Culturing HEK293TS cells by a shaking table, respectively culturing for 0h, 24h and 48h, respectively detecting the viable cell density and the cell viability after 0h and 24h, and carrying out flow detection on the titer of the virus after 48h of culture. The detection method of the invention has simple operation, short detection period, high detection flux and can avoidAvoids the problem of serum batch difference existing in the culture of HEK293T adherent cells; the virus diluent does not cause the reduction of the cell viability and the viable cell density of HEK293TS suspension cells; the invention adopts CO2The shaking table is used for culturing the virus, so that the cell survival rate, the viable cell density and the FACS infection titer are improved.

Description

Lentiviral titer detection method for HEK293TS suspension cells
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a method for detecting lentivirus titer of HEK293TS suspension cells.
Background
HEK293T cells were widely used for lentiviral packaging and titer detection. The adherent HEK293T cells are inevitably different in serum batch due to the adherent HEK293T cell culture problem, and the adherent cells are lower in detection flux and long in period compared with suspension cells in virus titer detection, and need pancreatin digestion treatment, so that the operation is complicated. And the HEK293TS suspension cell is cultured in a serum-free manner, so that the problem of difference between serum batches does not exist, and the HEK293TS suspension cell has the advantages of high experimental throughput, shorter whole detection process period, no need of pancreatin treatment, simplicity in operation and the like when being used for detecting the virus titer. However, there is no report on the use of this method for the determination of lentiviral transduction titers.
Disclosure of Invention
The invention aims to provide a method for detecting the lentivirus titer of HEK293TS suspension cells, which can solve the problems that the method for detecting the lentivirus titer by using adherent HEK293T cells in the background art is low in flux, long in period, needs pancreatin treatment and is complex to operate.
In order to achieve the purpose, the invention is realized by the following technical scheme: a method for detecting the lentivirus titer of HEK293TS suspension cells comprises the following steps:
s1, adjusting the density of HEK293TS suspension cells and mixing uniformly;
s2, uniformly mixing, and paving a proper amount of HEK293TS suspension cells in a 24-pore plate;
s3, pre-diluting the lentivirus solution by multiple times, adding a proper amount of pre-diluted virus solution into each hole of a 24-hole plate, and then supplementing a proper amount of virus diluent, wherein the virus diluent comprises a CD01 culture medium or a DPBS buffer solution, so that the volumes of the virus solutions in the holes are the same;
s4, use of CO2Culturing HEK293TS cells in a 24-well plate by using a shaking table, respectively culturing for 0h, 24h and 48h, respectively detecting the viable cell density and the cell viability after 0h and 24h, and carrying out flow detection on the titer of the virus after 48h of culture.
As a further improvement of the method for detecting the lentivirus titer of the HEK293TS suspension cells, the cell density was adjusted to 4.5X 10 in step S15cells/mL-9.5×105cells/mL。
As a further improvement of the above method for detecting the lentivirus titer of the HEK293TS suspension cells, 1ml of HEK293TS suspension cells were added to each well of a 24-well plate in step S2.
As a further improvement of the method for detecting the lentivirus titer of the HEK293TS suspension cells, in step S3, different amounts of pre-diluted virus solution are added to each well, and then virus dilutions are added to make the volumes of the virus solutions in the wells the same.
The invention has the beneficial effects that: 1) the method for detecting the lentivirus titer of the HEK293TS suspension cells can detect the lentivirus titer of the HEK293TS suspension cells, can avoid the problem of difference between serum batches inevitably existing in adherent HEK293T cell culture, has short detection period, does not need pancreatin digestion treatment, and is simple to operate and high in detection flux; 2) according to the method for detecting the lentivirus titer of the HEK293TS suspension cells, the CD01 culture medium or the DPBS buffer solution is used as the virus diluent, so that the problem that the cell viability and the viable cell density of the suspension HEK293TS cells are reduced after the DMEM culture medium is added in the prior art can be solved, and therefore, the cell viability and the viable cell density of the suspension HEK293TS cells can be improved by adopting the CD01 culture medium; 3) in step S4 of the present invention, CO is used2The shaking table is used for culturing the virus, and CO is adopted in the prior art2Compared with the scheme of the incubator, the cell viability, the viable cell density and the FACS infection titer are obviously improved.
Drawings
FIG. 1 is a graph of comparative example 1 showing the comparison of mean lentiviral titers obtained using the prior art method for detecting lentiviral titers of HEK293T adherent cells with the method for detecting lentiviral titers of HEK293TS suspension cells of the present invention.
FIG. 2 is a graph showing comparative data of cell density measured in comparative example 2 using different dilutions.
FIG. 3 is comparative data of cell viability measured using different dilutions in comparative example 2.
FIG. 4 shows the use of CO in comparative example 32Incubator and CO2Comparative data on cell viability obtained with the shaker culture mode.
FIG. 5 shows the use of CO in comparative example 32Incubator and CO2Comparative data on cell density obtained in the shaker culture mode.
FIG. 6 shows the use of CO in comparative example 32Incubator and CO2And (4) comparison data of lentivirus titer detected by a shaking table culture mode.
FIG. 7 is a comparison of lentivirus titers obtained in comparative example 4 using HEK293TS suspension cells at different cell densities.
The values on the coordinate axes in FIGS. 1, 2, 5, 6, 7, e.g. 5.00E +05 for 5X 105In the same way, 2.50E +09 represents 2.5X 109The other numerical values correspond to the above-mentioned exemplary expressions.
Detailed Description
The technical solutions of the present invention are described clearly and completely by the following embodiments, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A method for detecting the lentivirus titer of HEK293TS suspension cells comprises the following steps:
s1, HEK293TS suspension cells were adjusted to 8X 10 cell density5cells/mL;
S2, uniformly mixing, and paving in a 24-hole plate according to 1mL per hole;
s3, pre-diluting the virus by 100 times, respectively adding 1, 10 and 100 mu L of pre-diluted virus into a 24-well plate, and correspondingly adding 99, 90 and 0 mu L of virus diluent into the corresponding well, wherein the virus diluent is a CD01 culture medium;
s4, putting the 24-hole plate into CO2And (3) shaking the platforms, culturing for 0h, 24h and 48h respectively, uniformly mixing, sampling and detecting the living cell density and the living rate of the cells, directly and uniformly mixing by using a discharging gun, and cleaning, incubating the antibody, cleaning and carrying out flow detection on the virus titer after culturing for 48h after sampling.
Example 2
A method for detecting the lentivirus titer of HEK293TS suspension cells comprises the following steps:
s1, HEK293TS suspension cells were adjusted to 4.5X 10 cell density5cells/mL;
S2, uniformly mixing, and paving in a 24-hole plate according to 1mL per hole;
s3, pre-diluting the virus by 10 times, adding 20, 6.67, 2.22 and 0.74 mu L of pre-diluted virus into a 24-well plate respectively, and correspondingly adding 80, 93.33, 97.78 and 99.26 mu L of virus diluent which is a CD01 culture medium;
s4, putting the 24-hole plate into CO2And (3) shaking the platforms, culturing for 0h, 24h and 48h respectively, uniformly mixing, sampling and detecting the living cell density and the living rate of the cells, directly and uniformly mixing by using a discharging gun, and cleaning, incubating the antibody, cleaning and carrying out flow detection on the virus titer after culturing for 48h after sampling.
Example 3
A method for detecting the lentivirus titer of HEK293TS suspension cells comprises the following steps:
s1, HEK293TS suspension cells were adjusted to 9.5X 10 cell density5cells/mL;
S2, uniformly mixing, and paving in a 24-hole plate according to 1mL per hole;
s3, pre-diluting the virus by 50 times, adding 20, 6.67, 2.22 and 0.74 mu L of pre-diluted virus into a 24-well plate respectively, and correspondingly adding 80, 93.33, 97.78 and 99.26 mu L of virus diluent which is DPBS buffer solution;
s4, putting the 24-hole plate into CO2Shaking table, culturing for 0h, 24h, 48h, mixing well, sampling, detecting viable cell density and viable rate of cells, and usingAnd directly and uniformly mixing the components in a gun, and after sampling, cleaning, incubating the antibody, cleaning, and performing flow detection on the virus titer after culturing for 48 hours.
Comparative example 1
Comparing the lentivirus titer detection method of the HEK293T adherent cells in the prior art with the lentivirus titer detection method of the HEK293TS suspension cells to perform a titer detection comparison test on the same lentiviruses, the specific scheme is as follows:
the method for detecting the lentivirus titer of the HEK293T adherent cells in the prior art specifically comprises the following steps: HEK293T adherent cells were adjusted to density 4E +05cells/mL, uniformly mixing, spreading on a 24-well plate according to 0.5mL per well, randomly taking 3 wells after 24 hours, counting, and taking the average value of 4.39 multiplied by 105cells, pre-diluting virus 10 times, adding pre-diluted virus 20, 6.67, 2.22, 0.74 μ L, respectively, adding virus diluent 80, 99.33, 97.78, 99.26 μ L, respectively, adding CO 01 medium, respectively2And (3) adding 0.5mL of fresh culture medium into each hole after 24 hours in an incubator, continuously culturing for 24 hours, removing the supernatant, adding 100 mu L of pancreatin for digestion, stopping digestion by using 400 mu L of fresh culture medium, uniformly mixing, sampling, washing, incubating antibodies, washing and carrying out flow detection.
The lentivirus titer detection method of HEK293TS suspension cells is to adjust the cell density of HEK293TS suspension cells to 1.5 multiplied by 105cells/mL, and spreading the mixture in a 24-hole plate according to 1mL per hole after uniformly mixing; pre-diluting lentivirus 10 times, adding pre-diluted lentivirus 20, 6.67, 2.22, and 0.74 μ L, respectively, adding virus diluent 80, 99.33, 97.78, and 99.26 μ L, respectively, adding CD01 medium, and adding CO2And performing shake culture for 48h, uniformly mixing, sampling, cleaning, incubating the antibody, cleaning and performing flow detection.
By comparing the detection processes, the method for detecting the lentivirus titer of the HEK293TS suspension cells is simple and convenient to operate, does not need pancreatin digestion treatment, and can improve the detection efficiency.
As can be seen from fig. 1, when the infection titer of the same virus is detected, when the lentiviral titer detection is performed by using the HEK293TS suspension cell of the present invention and the HEK293T adherent cell of the prior art, the significant analysis results of the lentivirus are not different, and the detection results are consistent, which proves that the accuracy of the lentiviral titer detection performed by using the HEK293TS suspension cell of the present invention is high, and the HEK293TS suspension cell can completely replace the HEK293T adherent cell for the lentiviral titer detection; meanwhile, compared with the results of detecting the lentivirus titer by using the HEK293TS suspension cells in the prior art, the result of detecting the lentivirus titer by using the HEK293T adherent cells is higher in value, and the detection sensitivity can be improved.
Comparative example 2
The effect of different virus diluents on the cell growth is contrasted, and the specific scheme is as follows:
the cell density of the suspension of HEK293TS was adjusted to 6X 105And cells/mL, uniformly mixing, paving the mixture on a 24-well plate according to 1mL of each well, adding different virus diluents with the diluent of 100 mu L into each well, respectively culturing for 0h, 24h and 48h, uniformly mixing, and sampling to detect the viable cell density and the viable rate of the cells. The virus diluent respectively selects a D10 culture medium, a CD01 culture medium, a DBPS buffer solution and a mixture of the three substances and a three-antibody, wherein the formula of the D10 culture medium is a DMEM culture medium +10% FBS, the CD01 culture medium is a Transpro CD01 culture medium, the D10 culture medium is a commercial culture medium and can be used for HEK293TS suspension culture and virus packaging, and the virus of the harvested virus supernatant exists in a CD01 culture medium. DBPS buffer is a commercial buffer that is included in the purification process after virus packaging or in the finished product. The three-antibody is a mixed solution (100 multiplied by three-antibody) of penicillin-streptomycin-gentamicin, the three-antibody has the function of preventing bacteria from being introduced in the virus purification process, so that HEK293TS is polluted in the virus detection process and the detection experiment fails, and the addition amount of the three-antibody is 1X of working concentration.
As can be seen from fig. 2 and 3, the use of DMEM medium in the virus dilution resulted in a decrease in the cell viability and viable cell density of the suspended HEK293TS cells. The virus diluent selects a CD01 culture medium and a DPBS buffer solution or adds three antibodies into the two culture media, has no influence on the growth of HEK293TS cells, and proves that both the CD01 culture medium and the DPBS buffer solution can be used as the virus diluent.
Comparative example 3
Comparison ofCO is used in step S42Incubator and CO2The culture mode of the shaking table has influence on the growth of HEK293TS suspension cells and virus titer detection, and the specific scheme is as follows:
adjusting the cell density of the suspended HEK293TS to 8E +05cells/mL, uniformly mixing, spreading on a 24-well plate according to 1mL per well, pre-diluting the virus by 100 times, respectively adding 1, 10 and 100 mu L of the pre-diluted virus, correspondingly adding 99, 90 and 0 mu L of virus diluent (culture medium CD 01) into CO respectively2Incubator and CO2Shaking table culturing for 0h, 24h and 48h, mixing uniformly, sampling, detecting the viable cell density and the viable rate of the cells, and performing flow detection on the virus titer for 48 h.
As can be seen from FIGS. 4-6, the HEK293TS suspension cells were treated with CO after virus addition2The shaking table culture mode is adopted, and the cell viability, the viable cell density and the FACS infection titer of HEK293TS suspension cells are all higher than those of the HEK293TS suspension cells2The culture mode of the incubator is higher.
Comparative example 4
In the comparison step S1, a comparison test of lentivirus titer detection is performed using HEK293TS suspension cells of different cell densities, and the specific scheme is as follows:
the cell density of HEK293TS suspension cells was adjusted to 4.5X 105cells/mL、5.5×105cells/mL、6.5×105cells/mL、7.5×105cells/mL、8.5×105cells/mL、9.5×105cells/mL, uniformly mixing, spreading on a 24-well plate according to 1mL per well, pre-diluting the virus by 10 times, respectively adding 20, 6.67, 2.22 and 0.74 mu L of the pre-diluted virus, correspondingly adding 80, 99.33, 97.78 and 99.26 mu L of virus diluent which is CD01 culture medium, respectively adding CO2And performing shake culture for 48h, uniformly mixing, sampling, cleaning, incubating the antibody, cleaning and performing flow detection.
As can be seen from FIG. 7, the cell density of HEK293TS suspension cells was 4.5X 105-9.5×105The virus titer detection results in the cell/mL range have no significant difference, and the cell density of HEK293TS suspension cells is proved to be 4.5 multiplied by 105-9.5×105The result of detecting the virus titer in the cell/mL range has stability.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (4)

1. A method for detecting the lentivirus titer of HEK293TS suspension cells is characterized in that: which comprises the following steps:
s1, adjusting the density of HEK293TS suspension cells and mixing uniformly;
s2, uniformly mixing, and paving a proper amount of HEK293TS suspension cells in a 24-pore plate;
s3, pre-diluting the lentivirus solution by multiple times, adding a proper amount of pre-diluted virus solution into each hole of a 24-hole plate, and then supplementing a proper amount of virus diluent, wherein the virus diluent comprises a CD01 culture medium or a DPBS buffer solution, so that the volumes of the virus solutions in the holes are the same;
s4, use of CO2Culturing HEK293TS cells in a 24-well plate by using a shaking table, respectively culturing for 0h, 24h and 48h, respectively detecting the viable cell density and the cell viability after 0h and 24h, and carrying out flow detection on the titer of the virus after 48h of culture.
2. The method for detecting the lentivirus titer of HEK293TS suspension cells of claim 1, wherein the method comprises the steps of: in step S1, the cell density was adjusted to 4.5X 105cells/mL-9.5×105cells/mL。
3. The method for detecting the lentivirus titer of HEK293TS suspension cells of claim 1, wherein the method comprises the steps of: in step S2, 1ml of HEK293TS suspension cells were added to each well of the 24-well plate.
4. The method for detecting the lentivirus titer of HEK293TS suspension cells of claim 1, wherein the method comprises the steps of: in step S3, pre-diluted virus solutions with different amounts are added to each well, and then the virus diluent is added to make the volumes of the virus solutions in the wells the same.
CN202210047969.9A 2022-01-17 2022-01-17 Lentiviral titer detection method for HEK293TS suspension cells Pending CN114350595A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210047969.9A CN114350595A (en) 2022-01-17 2022-01-17 Lentiviral titer detection method for HEK293TS suspension cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210047969.9A CN114350595A (en) 2022-01-17 2022-01-17 Lentiviral titer detection method for HEK293TS suspension cells

Publications (1)

Publication Number Publication Date
CN114350595A true CN114350595A (en) 2022-04-15

Family

ID=81090510

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210047969.9A Pending CN114350595A (en) 2022-01-17 2022-01-17 Lentiviral titer detection method for HEK293TS suspension cells

Country Status (1)

Country Link
CN (1) CN114350595A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102134613A (en) * 2010-12-31 2011-07-27 中国人民解放军第三军医大学 Detection method of titer of recombinant lentivirus
CN107201334A (en) * 2016-03-16 2017-09-26 金宇保灵生物药品有限公司 Can be suspended the bovine kidney cells cultivated and its suspension culture method and application
CN107523555A (en) * 2016-06-22 2017-12-29 武汉光谷人福生物医药有限公司 The method for obtaining virus
CN108220227A (en) * 2017-12-27 2018-06-29 华农(肇庆)生物产业技术研究院有限公司 A kind of method for the culture newcastle disease virus that suspended by the continuous cell line that suspends entirely
CN109294976A (en) * 2018-11-13 2019-02-01 王晓柯 A kind of serum free medium for supporting HEK293 cell suspension cultures
CN110669871A (en) * 2019-10-17 2020-01-10 河北森朗生物科技有限公司 Method for measuring transduction titer of lentivirus
CN110713971A (en) * 2019-11-06 2020-01-21 深圳市菲鹏生物治疗股份有限公司 Serum-free suspension culture type 293T cell, preparation method thereof and virus packaging method
CN113265425A (en) * 2021-05-08 2021-08-17 苏州博腾生物制药有限公司 Suspension cell-based CAR-CD19 lentivirus preparation process

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102134613A (en) * 2010-12-31 2011-07-27 中国人民解放军第三军医大学 Detection method of titer of recombinant lentivirus
CN107201334A (en) * 2016-03-16 2017-09-26 金宇保灵生物药品有限公司 Can be suspended the bovine kidney cells cultivated and its suspension culture method and application
CN107523555A (en) * 2016-06-22 2017-12-29 武汉光谷人福生物医药有限公司 The method for obtaining virus
CN108220227A (en) * 2017-12-27 2018-06-29 华农(肇庆)生物产业技术研究院有限公司 A kind of method for the culture newcastle disease virus that suspended by the continuous cell line that suspends entirely
CN109294976A (en) * 2018-11-13 2019-02-01 王晓柯 A kind of serum free medium for supporting HEK293 cell suspension cultures
CN110669871A (en) * 2019-10-17 2020-01-10 河北森朗生物科技有限公司 Method for measuring transduction titer of lentivirus
CN110713971A (en) * 2019-11-06 2020-01-21 深圳市菲鹏生物治疗股份有限公司 Serum-free suspension culture type 293T cell, preparation method thereof and virus packaging method
CN113265425A (en) * 2021-05-08 2021-08-17 苏州博腾生物制药有限公司 Suspension cell-based CAR-CD19 lentivirus preparation process

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
孙克宁等: "贴壁和悬浮状态293T细胞慢病毒包装效果的比较研究", 《河南农业大学学报》, vol. 45, no. 6, pages 668 - 671 *
王大宁;刘亚静;郑清炳;李智海;范飞;柳欣林;宋硕;顾颖;夏宁邵;李少伟;: "悬浮驯化HEK-293FT细胞表达人乳头瘤病毒16型假病毒及其冷冻电镜结构解析", 病毒学报, no. 05 *
田博;吴彬;张群伟;毕建进;王澜;朱宝珍;耿越;吴祖泽;: "悬浮培养HEK-293 N3S细胞生产重组腺病毒Ad-GFP的实验研究", 生物工程学报, no. 05 *

Similar Documents

Publication Publication Date Title
Ernebjerg et al. Distinct growth strategies of soil bacteria as revealed by large-scale colony tracking
CN111690570B (en) Glutamine transaminase producing strain
CN108588188B (en) Quantitative detection method for microorganisms in mixed microorganism fermentation process
JP6737813B2 (en) Small-scale culture of suspension cells
CN111024949A (en) Biological activity analysis method of recombinant anti-VEGFR 2 monoclonal antibody and application thereof
CN110257253B (en) Mutant strain of geotrichum and application thereof
Möller et al. Model‐based identification of cell‐cycle‐dependent metabolism and putative autocrine effects in antibody producing CHO cell culture
CN115975925B (en) Method for inducing human pluripotent stem cells to differentiate into natural killer cells by variable-speed suspension
CN109082455B (en) Method for rapidly detecting total coliform in drinking water
CN114350595A (en) Lentiviral titer detection method for HEK293TS suspension cells
CN109913404A (en) The preparation method of infections chicken cloacal bursa virus live vaccine
CN110885766B (en) Biological agent for degrading organic matters in amino acid mother liquor
CN108531442B (en) Insect cell line cultured in serum-free suspension manner and application thereof
CN111020060A (en) Method for determining heterophilic murine leukemia virus titer by plaque staining
Wright et al. Single-cell technologies to understand the mechanisms of cellular adaptation in chemostats
CN114958959A (en) Processing method of human mesenchymal stem cell IDO1 activity data
CN113046306A (en) Culture method of pluripotent stem cells
CN110964695A (en) Cell strain and method for detecting rhIL-12 in vitro activity by proliferation thereof
CN111286500A (en) Coenzyme Q production by combining plasma action with oxygen limitation10Method (2)
CN106591243B (en) A method of improving infectious bursal disease virus titer plateaus
CN110904025A (en) Serum-free suspension domestication method of Vero cells
CN111849918A (en) Method for researching target gene regulated and controlled by histone methylation in chicken SSCs
CN112011505B (en) Umbilical cord mesenchymal stem cell separation method
CN117230258B (en) EB virus detection method of culture amplification combined PCR for improving sensitivity
CN109679925A (en) The preparation method and products thereof of duck tembusu virus liquid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination